Neogen Corp (NEOG): Shareholders' Equity
$2.09B
As of 2026-05-31
-12.6%
3-year compound annual growth
+20.0%
5-year compound annual growth
+17.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | $2.09B | +1.0% | 2026-07-30, Balance as of period end |
| 2025-05-31 | $2.07B | -34.1% | 2026-07-30, Balance as of period end |
| 2024-05-31 | $3.14B | +0.3% | 2026-07-30, Balance as of period end |
| 2023-05-31 | $3.13B | +253.2% | 2025-07-30, Balance as of period end |
| 2022-05-31 | $887.37M | +5.6% | 2024-07-30, Balance as of period end |
| 2021-05-31 | $840.38M | +15.9% | 2023-08-15, Balance as of period end |
| 2020-05-31 | $725.18M | +13.7% | 2022-07-27, Balance as of period end |
| 2019-05-31 | $637.90M | +13.9% | 2021-07-30, Balance as of period end |
| 2018-05-31 | $560.17M | +18.7% | 2020-07-30, Balance as of period end |
| 2017-05-31 | $471.76M | +16.7% | 2019-07-30, Balance as of period end |
| 2016-05-31 | $404.16M | +15.2% | 2018-07-27, Balance as of period end |
| 2015-05-31 | $350.96M | +14.6% | 2017-07-28, Balance as of period end |
| 2014-05-31 | $306.30M | +18.6% | 2016-07-29, Balance as of period end |
| 2013-05-31 | $258.29M | +17.9% | 2015-07-30, Balance as of period end |
| 2012-05-31 | $219.05M | +15.8% | 2014-07-30, Balance as of period end |
| 2011-05-31 | $189.10M | +23.6% | 2013-07-30, Balance as of period end |
| 2010-05-31 | $153.05M | n/a | 2012-07-30, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Neogen Corp (NEOG) | 2026-05-31 | $2.09B | +1.0% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $368.00M | -47.5% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $1.09B | +0.2% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $1.92B | -35.7% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $1.61B | +0.6% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $671.39M | -23.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗